Acquisition and eradication of P. aeruginosa in young children with CF

P. Merkus

Source: Breathe 2009; 5: 358
Journal Issue: June
Disease area: Paediatric lung diseases

PDF journal article, handout or slides

Rating: 3
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Merkus. Acquisition and eradication of P. aeruginosa in young children with CF. Breathe 2009; 5: 358

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Acquisition and eradication of P. aeruginosa in young children with cystic fibrosis
Source: Eur Respir J 2009; 33: 305-311
Year: 2009



Newly acquired pseudomonas aeruginosa in Belgian cystic fibrosis-patients: does the patients‘ P. aeruginosa genotype correlate with environmental genotypes?
Source: Eur Respir J 2006; 28: Suppl. 50, 485s
Year: 2006

Prevalence of pseudomonas aeruginosa in pancreatic sufficient CF patients in Scandinavia
Source: Eur Respir J 2006; 28: Suppl. 50, 714s
Year: 2006

Eradication of Pseudomonas aeruginosa in cystic fibrosis patients
Source: Eur Respir J 2006; 27: 653
Year: 2006


Omics-based tracking of Pseudomonas aeruginosa persistence in “eradicated” cystic fibrosis patients
Source: Eur Respir J, 57 (4) 2000512; 10.1183/13993003.00512-2020
Year: 2021



Persistence and genetic adaptation of Pseudomonas aeruginosa in patients with COPD.
Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Year: 2020




Pseudomonas aeruginosa in patients with cystic fibrosis - a comparison of early eradication and conventional therapy
Source: Eur Respir J 2004; 24: Suppl. 48, 385s
Year: 2004

Can LCI predict new Pseudomonas aeruginosa colonization among CF patients?>
Source: International Congress 2017 – What is the future for paediatric respiratory physiology and sleep?
Year: 2017



Comparative in vitro activity of fluoroquinolones against P. aeruginosa isolated from Greek CF patients
Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis
Year: 2020


Proteomic profile of cystic fibrosis sputum cells in adults chronically infected with Pseudomonas aeruginosa
Source: Eur Respir J, 50 (1) 1601569; 10.1183/13993003.01569-2016
Year: 2017



Efficacy of Pseudomonas aeruginosa eradication regimens in bronchiectasis
Source: Eur Respir J , 49 (4)  1600851; DOI: 10.1183/13993003.00851-2016
Year: 2017



Acinetobacter baumanii and Stenotrophomonas maltophilia are associated with lower airway infections in tracheostomised children and young adults.
Source: International Congress 2017 – New insights into paediatric respiratory infections
Year: 2017

Eradication of Pseudomonas aeruginosa in cystic fibrosis
Source: Eur Respir J 2006; 27: 438-439
Year: 2006


Variability of ß-lactamase resistance Pseudomonas aeruginosa genes infecting patients with cystic fibrosis
Source: Virtual Congress 2021 – Back to infection basics
Year: 2021


Detection of Pseudomonas aeruginosa infection in cystic fibrosis patients by eNose technology
Source: International Congress 2018 – Latest developments in cystic fibrosis
Year: 2018




Factors associated with infection by Pseudomonas aeruginosa in adult cystic fibrosis
Source: Eur Respir J 2005; 26: 651-656
Year: 2005



Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients
Source: Eur Respir J 2008; 31: 822-829
Year: 2008



Survey of Pseudomonas aeruginosa genotypes in colonised cystic fibrosis patients
Source: Eur Respir J 2006 Oct 01;28(4):740-747
Year: 2006



Prevalence of S. pneumoniae colonization and serotypes in sputum of vaccine-naive adults with cystic fibrosis.
Source: International Congress 2019 – Complex respiratory infections in clinical practice
Year: 2019